Chiara Ambrogio, the researcher of UniTO, the University of Torino, has been awarded 2 million for research The European Research Council, the European Union body which funds scientific research, will allocate 2 million euros to support the study of mutations of the KRAS gene made by Dr. Chiara Ambrogio, of the Molecular Biotechnology Center of the University of Torino.

This gene is one of the main causes of lung, pancreatic and colon cancer. The project on which Dr. Ambrogio is working focuses on the study of the mutations of the KRAS gene, which triggers an anomalous cellular growth, leading to lung, pancreatic and colon cancer.
Find out more about the project on www.unitonews.it